This information was published on 2025-09-29T09:10:50 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2589820 (IR 1877057) |
| (220) |
28 Aug 2025
|
| (300) |
US, 06 Mar 2025, 99071025
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections; pharmaceutical preparations for use in stimulating lymphocyte production; pharmaceutical preparations for maintenance of lymphocyte counts. Class 42 Product research and development; providing medical and scientific research information. Class 44 Providing medical information via a website. |
| (540) | THANKTHEMBA |
| (550) | Word |
| (730) |
ImmunityBio, Inc.
|
Find out more about publications on the About page.